Haematology Oncology General Medicine Strong — universal oncology outcome measure; required for clinical trial eligibility
ECOG / WHO Performance Status
Eastern Cooperative Oncology Group (ECOG) / WHO performance status scale describes a patient's level of functioning in terms of ability to care for themselves and daily activity. Guides treatment decisions in oncology.
References
- Oken MM, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–655.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Folinic Acid (Calcium Folinate / Leucovorin) · Antidote / Chemotherapy Support
- Phenytoin / Fosphenytoin · Antiepileptic — Status Epilepticus (Second-Line)
- Levetiracetam (IV) · Antiepileptic — Status Epilepticus (Second-Line)
- Zoledronic Acid · Bisphosphonate (IV)
- Denosumab · RANK Ligand Inhibitor (Anti-resorptive)
- Cisplatin · Platinum Chemotherapy — Head and Neck Cancer
Pathways
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO
- Anticoagulation Reversal · BSH 2016 / ESC
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.